FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111151753> ?p ?o ?g. }

• W2111151753 endingPage "5839" @default.
• W2111151753 startingPage "5829" @default.
• W2111151753 abstract "Abstract Purpose: The increasing incidence of osteonecrosis of the jaw and its possible association with high cumulative doses of bisphosphonate led us to study the effects of high doses of zoledronic acid (ZA) on bone remodeling. Experimental Design: Five-week-old C57BL6 mice were treated with saline or ZA weekly for 3 weeks at increasing doses (0.05-1 mg/Kg). Effects of ZA on bone remodeling were studied using standard assays. Results: We observed an increase in bone mineral density and content in treated animals at doses of 0.05 mg/Kg, which was not further enhanced at higher doses of ZA. Trabecular bone volume at the proximal tibia and the distal femur assessed by histomorphometry and microCT, respectively, increased significantly in ZA-treated groups. There was however no difference between 0.5 and 1 mg/kg, suggesting a ceiling effect for ZA. ZA led to decreased numbers of osteoclasts and osteoblasts per bone perimeter that paralleled a significant reduction of serum levels of TRAC5b and osteocalcin in vivo. Effects on osteoblasts were confirmed in in vitro assays. Mechanical testing of the femur showed increased brittleness in ZA-treated mice. Conclusions: High doses of ZA inhibit both osteoclast and osteoblasts function and bone remodeling in vivo interfering with bone mechanical properties. No dose response was noted beyond 0.5 mg/kg suggesting that lower doses of ZA may be adequate in inhibiting bone resorption. Our data may help inform future studies of ZA use with respect to alternate and lower doses in the treatment of patients with cancer bone disease. (Clin Cancer Res 2009;15(18):5829–39)" @default.
• W2111151753 created "2016-06-24" @default.
• W2111151753 creator A5000527476 @default.
• W2111151753 creator A5004991997 @default.
• W2111151753 creator A5005425076 @default.
• W2111151753 creator A5006954456 @default.
• W2111151753 creator A5032464400 @default.
• W2111151753 creator A5032638450 @default.
• W2111151753 creator A5043322435 @default.
• W2111151753 creator A5045740077 @default.
• W2111151753 creator A5056316854 @default.
• W2111151753 creator A5057460944 @default.
• W2111151753 creator A5066816851 @default.
• W2111151753 creator A5070359568 @default.
• W2111151753 creator A5083528886 @default.
• W2111151753 creator A5083655413 @default.
• W2111151753 creator A5084530923 @default.
• W2111151753 creator A5089868294 @default.
• W2111151753 creator A5090686439 @default.
• W2111151753 creator A5091207345 @default.
• W2111151753 date "2009-09-14" @default.
• W2111151753 modified "2023-10-14" @default.
• W2111151753 title "High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties" @default.
• W2111151753 cites W1862785984 @default.
• W2111151753 cites W1967967197 @default.
• W2111151753 cites W1975825361 @default.
• W2111151753 cites W1990119475 @default.
• W2111151753 cites W1993232754 @default.
• W2111151753 cites W1994414479 @default.
• W2111151753 cites W1996898338 @default.
• W2111151753 cites W2008346525 @default.
• W2111151753 cites W2011388217 @default.
• W2111151753 cites W2013783720 @default.
• W2111151753 cites W2022094899 @default.
• W2111151753 cites W2024887507 @default.
• W2111151753 cites W2025707250 @default.
• W2111151753 cites W2035337493 @default.
• W2111151753 cites W2041367424 @default.
• W2111151753 cites W2044303380 @default.
• W2111151753 cites W2044532264 @default.
• W2111151753 cites W2051516578 @default.
• W2111151753 cites W2057332307 @default.
• W2111151753 cites W2060040289 @default.
• W2111151753 cites W2064200002 @default.
• W2111151753 cites W2071108987 @default.
• W2111151753 cites W2071426740 @default.
• W2111151753 cites W2075702320 @default.
• W2111151753 cites W2082239474 @default.
• W2111151753 cites W2087378917 @default.
• W2111151753 cites W2087549132 @default.
• W2111151753 cites W2093164779 @default.
• W2111151753 cites W2093395043 @default.
• W2111151753 cites W2107118598 @default.
• W2111151753 cites W2107208293 @default.
• W2111151753 cites W2110466791 @default.
• W2111151753 cites W2112507082 @default.
• W2111151753 cites W2115871403 @default.
• W2111151753 cites W2122473686 @default.
• W2111151753 cites W2123171945 @default.
• W2111151753 cites W2136887207 @default.
• W2111151753 cites W2137302084 @default.
• W2111151753 cites W2141521877 @default.
• W2111151753 cites W2144168648 @default.
• W2111151753 cites W2150904792 @default.
• W2111151753 cites W2152409486 @default.
• W2111151753 cites W2161690532 @default.
• W2111151753 cites W2163852287 @default.
• W2111151753 cites W2165326697 @default.
• W2111151753 cites W2176744910 @default.
• W2111151753 cites W4242024627 @default.
• W2111151753 doi "https://doi.org/10.1158/1078-0432.ccr-09-0426" @default.
• W2111151753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19737962" @default.
• W2111151753 hasPublicationYear "2009" @default.
• W2111151753 type Work @default.
• W2111151753 sameAs 2111151753 @default.
• W2111151753 citedByCount "89" @default.
• W2111151753 countsByYear W21111517532012 @default.
• W2111151753 countsByYear W21111517532013 @default.
• W2111151753 countsByYear W21111517532014 @default.
• W2111151753 countsByYear W21111517532015 @default.
• W2111151753 countsByYear W21111517532016 @default.
• W2111151753 countsByYear W21111517532017 @default.
• W2111151753 countsByYear W21111517532018 @default.
• W2111151753 countsByYear W21111517532019 @default.
• W2111151753 countsByYear W21111517532020 @default.
• W2111151753 countsByYear W21111517532021 @default.
• W2111151753 countsByYear W21111517532022 @default.
• W2111151753 countsByYear W21111517532023 @default.
• W2111151753 crossrefType "journal-article" @default.
• W2111151753 hasAuthorship W2111151753A5000527476 @default.
• W2111151753 hasAuthorship W2111151753A5004991997 @default.
• W2111151753 hasAuthorship W2111151753A5005425076 @default.
• W2111151753 hasAuthorship W2111151753A5006954456 @default.
• W2111151753 hasAuthorship W2111151753A5032464400 @default.
• W2111151753 hasAuthorship W2111151753A5032638450 @default.
• W2111151753 hasAuthorship W2111151753A5043322435 @default.
• W2111151753 hasAuthorship W2111151753A5045740077 @default.
• W2111151753 hasAuthorship W2111151753A5056316854 @default.

• next